These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
Bologna, Italy. This pivotal global role within the Global Value & Market Access team is responsible for shaping global market access, pricing, evidence-generation, and health policy strategies for Alfasigma’s specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans that support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working … Lue lisää
Raleigh, NC, Yhdysvallat. Haluamme rekrytoida erittäin motivoitunutta ja yksityiskohtiin perehtynyttä harjoittelijaa osaksi lääketieteellistä ja tieteellistä asiointia sekä markkinoillepääsyä koskevaa tiimiämme. Tämä harjoittelu tarjoaa ainutlaatuisen mahdollisuuden hankkia käytännön kokemusta markkinoillepääsyyn liittyvistä strategisista ja operatiivisista näkökohdista johtavana biotieteiden yrityksenä toimivassa ympäristössä. Harjoittelija auttaa aloitteissa, jotka varmistavat innovatiivisten lääkkeiden optimaalisen saatavuuden potilaille … Lue lisää
Remote, US. At iRhythm, you’ll have the opportunity to grow your skills and your career while impacting the lives of people around the world. iRhythm is shaping a future where everyone, everywhere can access the best possible cardiac health solutions. Every day, we collaborate, create, and constantly reimagine what’s possible. We think big and move fast, driven by our commitment … Lue lisää
Hyderabad, India. The Global HEOR Value Writing Senior Associate plays a critical role in supporting Amgen’s global market access strategy through high-quality Health Technology Assessment (HTA) deliverables. This role collaborates closely with team lead and Global HEOR Product Leads to ensure alignment with product strategy. The Value Writing Senior Associate develops Global Value Dossiers (GVDs), US AMCP dossiers, EU JCA … Lue lisää
Cambridge, MA, US. The Director, US Health Economics and Outcomes Research (HEOR) & Real World Evidence (RWE) is responsible for identifying real-world and economic evidence needs and developing the real-world, clinical, humanistic, and economic evidence generation plans in collaboration with internal business partners to support the value of our products for US healthcare providers, population-health decision makers, and other external … Lue lisää
Hanki 100%-käyttöoikeus PRo:n avulla
Ilmainen pääsy päättyy tähän
Näet vain 30% roolia, ja tiedot ovat 7 päivää vanhoja. Pro-versiolla saat heti käyttöösi 100% roolia. 367 avointa työpaikkaa Pro-jäsenille tänään.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
Arvostamme yksityisyyttäsi. Käytämme evästeitä parantaaksemme käyttökokemustasi verkkosivustollamme, personoidaksemme sisältöä ja mainoksia sekä analysoidaksemme liikennettä. Voit valita, mitkä evästeet sallit, ja voit peruuttaa suostumuksesi milloin tahansa. Lisätietoja on osoitteessa Evästekäytäntö.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
